TrialCardiovascular diabetology2022

Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial.

Lorenzo Nesti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.